SCHEMBL4465084

SCHEMBL4465084

CCOc1ccc(Nc2nc(C)cc3c2C(=O)OCC3)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 2/20 0.49
MAPT P10636 6/20 0.42
MAPK1 P28482 2/20 0.42
RXFP1 Q9HBX9 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
GAA P10253 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4064215 0.85 RAB9A (0.38) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4070413 0.84 ALDH1A1 (0.43) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL4074481 0.83 TYK2 (0.38) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4073806 0.83 KMT2A (0.41) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4249021 0.77 TYK2 (0.34) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4064392 0.74 CD38 (0.44) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL4069309 0.71 RECQL (0.45) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4063747 0.70 GAA (0.41) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4243904 0.70 KDM4E (0.52) KDM4EALDH1A1HPGDMAPTMAPK1
SCHEMBL4063497 0.68 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601736-B2 Such as 3,4-dihydro-pyrano[3,4-c]pyridine-1-on; cytokine suppressive antiinflammatory drugs; analgesics SK CHEMICALS CO., LTD. (KR) 2009-10-13 US claimed
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same SK CHEMICALS CO., LTD. (KR) 2007-11-01 US claimed
US-7601736-B2 Such as 3,4-dihydro-pyrano[3,4-c]pyridine-1-on; cytokine suppressive antiinflammatory drugs; analgesics SK CHEMICALS CO., LTD. (KR) 2009-10-13 US disclosed
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same SK CHEMICALS CO., LTD. (KR) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254909-A1 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same IL5, IL1B, P2RY4 KDM4E 405/4885ALDH1A1 1008/4885HPGD 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.